In head and neck squamous cell carcinoma, VAV2 activity forms a Rho-Myc-YAP signaling axis responsible for promoting a stem cell-like regenerative proliferation of tumor cells [30]. Here, MYC is linked to head and neck squamous cell carcinoma.